| domain | cleerlyhealth.com |
| summary | The CREDENCE trial, a prospective, multicenter study, compared Cleerly ISCHEMIA to FFRCT and stress testing in diagnosing ischemia. The results showed that Cleerly ISCHEMIA had superior diagnostic accuracy and area under the curve, as validated by 868 fractional flow reserve (FFR) measurements, considered the gold standard for ischemia detection.
Cleerly ISCHEMIA's software quantifies atherosclerosis by measuring plaque volume, composition, length, and location, assessing stenosis severity in both 2D diameter and area, as well as 3D lumen and vessel volume. This tool offers a workflow to determine the likelihood of ischemia, potentially minimizing unnecessary additional testing and boosting diagnostic confidence. |
| title | Personalized Analysis and Treatment of Heart Disease | Cleerly |
| description | Cleerly determines your risk of heart attack by performing a non-invasive whole heart assessment to identify, characterize, and quantify plaque buildup. |
| keywords | ischemia, demo, more, request, providers, patients, plaque, analysis, billing, guidelines, blog, patient, products, events, coverage, contact, solution |
| upstreams |
cholesterolcode.com |
| downstreams |
|
| nslookup | A 199.60.103.133, A 199.60.103.33 |
| created | 2024-11-29 |
| updated | 2025-10-23 |
| summarized | 2025-10-23 |
|
|